Adverse events due to drug consumption can damage the physical and mental wellbeing of patients and are a huge economic burden for the healthcare system (Sultana et al., 2013).
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.